Table 1 Demographic characteristics of the included studies (1.25 group/1.75 group)
Study (year) | Study design | Nation | Participation | Sex ratio (M/F) | Intervention (mmol/L) | Sample size | Mean age (year) | Follow-up time (month) | Dropouts |
|---|---|---|---|---|---|---|---|---|---|
Stein (1995) [21] | RCT | Britain | CAPD | 29.l4/28.l 5 | 1.25/1.75 | 43/43 | 55.3 ± 2.1/ 54.2 ± 2.9 | 12 | 16/15 |
Johnson (1996) [22] | RCT | Australia | CAPD | 5.6/3.8 | 1.25/1.75 | 22/23 | 59.8 ± 3.1/ 60.2 ± 2.8 | 12 | 11/12 |
Sa’nchez (2004) [23] | RCT | Spain | CAPD | NR | 1.25/1.75 | 22/22 | 56 ± 11 (total) | 12 | 8/12 |
Jing (2009) [11] | RCT | China | CAPD | 13.20/8.16 | 1.25/1.75 | 33/24 | 58.6 ± 13.4/ 52.6 ± 15.6 | 12 | 2/2 |
Kang (2012) [24] | Non- RCT | South Korea | PD | 22.23/104.86 | 1.25/1.75 | 46/190 | 49.2 ± 10.8/ 49.5 ± 13.2 | 24 | 0/0 |
Liang (2014) [12] | Non- RCT | China | CAPD | 12.8/13.7 | 1.25/1.75 | 20/20 | 52.87 ± 12.0/ 57.0 ± 13.0 | 12 | 0/0 |
Wang (2016) [13] | Non- RCT | China | CAPD | 13.17/14.16 | 1.25/1.75 | 30/30 | 56.75 ± 10.21/ 54.15 ± 7.75 | 12 | 0/0 |